Microscopic Image of an Ependymoma

More new step for accurate diagnosis of cancer. Researchers in France and the UK have identified a link between specific chromosomal abnormalities and increased risk of death in children suffering from a fatal variant of brain cancer. The results could help develop a diagnostic test that identifies patients at increased risk for ependymoma, an intracranial gloomy which constitutes 10% of the central nervous system tumors in children. The findings, published in Clinical Cancer Research, could help to develop a diagnostic test that would identify younger patients with an increased risk of ependymoma and that may require more intensive treatment to survive the disease. 

The study, conducted by the Research Center of brain tumors at the University of Nottingham (UK), could help to identify children with brain tumors have a more positive prognosis and thus propose as candidates for less intensive treatments. So generators suffer fewer side effects permanent disabilities affecting them the rest of his life. 

The team investigated abnormal copies of chromosomes extracted cell ependymomas of 147 young British and French extractor surgery and chemotherapy and European children older than the first group who underwent surgery and radiotherapy. The aim of his work was to clarify whether the outlook is worse in those with the chromosomal abnormality.